Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Royalty Pharma Plc
RPRXRoyalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. Address: 110 East 59th Street, New York, NY, United States, 10022
Analytics
Objectif de Cours de WallStreet
44.83 USDRatio C/B
18.1133Rendement du dividende
3.06 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés RPRX
Analyse des dividendes RPRX
Croissance des dividendes sur 5 ans
–Croissance continue
3 annéesRatio de distribution Moyenne sur 5 ans
279 %Historique des dividendes RPRX
Valorisation des titres RPRX
financières RPRX
Résultats | 2019 | Dynamique |